ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) |
OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) |
OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(IRS employer identification no.) | |
(Address of principal executive offices) |
(Zip code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
$0.01 per share |
|
Accelerated Filer ☐ |
Non-accelerated Filer ☐ |
Smaller Reporting Company | |||
Emerging growth company |
Title of Each Class |
Number of Shares of Common Stock Outstanding as of February 18, 2021 | |
Common Stock | ||
Class B Common Stock |
ITEM 1. |
BUSINESS |
ITEM 1A. |
RISK FACTORS |
• | changes in demand for our products and for our customers’ end-products incorporating our products, as well as our ability to respond efficiently to such changes in demand, including changes in delivery lead times and the volume of product for which orders are accepted and the product shipped within an individual quarter; |
• | our ability to manage our supply chain, inventory levels, and our own manufacturing capacity or that of third-party partners, particularly in the event of delays or cancellations of significant customer orders or in the event of delays or cost increases associated within our supply chain; |
• | our ability to effectively coordinate changes in the mix of products we manufacture and sell, while managing our ongoing transition in organizational focus and manufacturing infrastructure to Advanced Products from Brick Products; |
• | our ability to provide and maintain a high level of sales and engineering support to an increasing number of demanding, high volume customers; |
• | the ability of our third party suppliers, and service subcontractors to provide us sufficient quantities of high quality products, components, and/or services on a timely and cost-effective basis; |
• | the effectiveness of our ongoing efforts to continuously reduce manufacturing costs and manage operating expenses; |
• | our ability to utilize our manufacturing facilities and personnel at efficient levels, maintaining sufficient production capacity and necessary manufacturing yields; |
• | our ability to plan, schedule, and execute capacity expansion, including the anticipated addition in 2021 of approximately 90,000 square feet to our Andover manufacturing facility; |
• | the timing of our new product introductions and our ability to meet customer expectations for timely delivery of fully qualified products; |
• | the timing of new product introductions or other competitive actions (e.g., product price reductions) by our competitors; |
• | the ability to hire, retain, and motivate qualified employees to meet the demands of our customers; |
• | intellectual property disputes; |
• | litigation-related costs, which may be significant; |
• | adverse economic conditions in the U.S. and those foreign countries in which we operate, as well as our ability to respond to unanticipated developments, such as the imposition of tariffs or trade restrictions; and |
• | adverse budgetary conditions within the U.S. government, particularly the Department of Defense, which continue to influence spending on current and anticipated programs into which we sell or anticipate to sell our products; |
• | costs related to compliance with increasing worldwide governance, quality, environmental, and other regulations; |
• | costs and consequences of disruption by third-parties of our global computer network and related resources; |
• | the effects of events outside of our control, including public health emergencies, natural disasters, terrorist activities, political risks, international conflicts, information security breaches, communication interruptions, and other force majeure |
• | volatility of the financial markets, notably the equity markets in the U.S.; |
• | uncertainty regarding the prospects of domestic and foreign economies, including the impact of volatile currency exchange rates; |
• | uncertainty regarding domestic and international political conditions, including tax, trade, and tariff policies; |
• | actual or anticipated fluctuations in our operating performance or that of our competitors; |
• | the performance and prospects of our major customers, including their adoption of technologies or standards other than those in which we specialize; |
• | announcements by us or our competitors of significant new products, technical innovations, or litigation; |
• | investor perception of the Company and the industry in which we operate; |
• | the liquidity of the market for our Common Stock, reflecting a relatively low trading float and relatively low average trading volumes; |
• | the uncertainty of the declaration and payment of future cash dividends on our Common Stock; and |
• | the concentration of ownership of our Common Stock by Dr. Vinciarelli, our Chairman of the Board, Chief Executive Officer, and President. |
ITEM 1B. |
UNRESOLVED STAFF COMMENTS |
ITEM 2. |
PROPERTIES |
ITEM 3. |
LEGAL PROCEEDINGS |
ITEM 4. |
MINE SAFETY DISCLOSURES |
ITEM 5. |
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES |
Month of Fourth Quarter 2020 |
Total Number of Shares Purchased |
Average Price Paid per Share |
Total Number of Shares Purchased Pursuant to November 2000 Plan |
Remaining Dollar Value of Shares Authorized For Purchase Pursuant to November 2000 Plan |
||||||||||||
October 1 — 31, 2020 |
— | $ | — | — | $ | 8,541,000 | ||||||||||
November 1 — 30, 2020 |
— | $ | — | — | $ | 8,541,000 | ||||||||||
December 1 — 31, 2020 |
— | $ | — | — | $ | 8,541,000 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
— | $ | — | — | $ | 8,541,000 | ||||||||||
|
|
|
|
|
|
|
|
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
|||||||||||||||||
Vicor Corporation |
$100.00 | $ | 165.57 | $ | 229.17 | $ | 414.36 | $ | 512.28 | $ | 1,011.18 | |||||||||||
S&P 500 Index |
$100.00 | $ | 111.96 | $ | 136.40 | $ | 130.42 | $ | 171.49 | $ | 203.04 | |||||||||||
S&P SmallCap 600 Index |
$100.00 | $ | 126.56 | $ | 143.30 | $ | 131.15 | $ | 161.03 | $ | 179.20 |
ITEM 6. |
SELECTED FINANCIAL DATA |
Year Ended December 31, |
||||||||||||||||||||
Statement of Operations Data |
2020 |
2019 |
2018 |
2017 |
2016 |
|||||||||||||||
(In thousands, except per share data) |
||||||||||||||||||||
Net revenues |
$ | 296,576 | $ | 262,977 | $ | 291,220 | $ | 227,830 | $ | 200,280 | ||||||||||
Income (loss) from operations |
17,368 | 13,821 | 32,059 | (1,360 | ) | (6,314 | ) | |||||||||||||
Consolidated net income (loss) |
17,922 | 14,109 | 31,846 | 258 | (6,261 | ) | ||||||||||||||
Net income (loss) attributable to noncontrolling interest |
12 | 11 | 121 | 91 | (14 | ) | ||||||||||||||
Net income (loss) attributable to Vicor Corporation |
17,910 | 14,098 | 31,725 | 167 | (6,247 | ) | ||||||||||||||
Net income (loss) per share — basic attributable to Vicor Corporation |
0.42 | 0.35 | 0.80 | 0.00 | (0.16 | ) | ||||||||||||||
Net income (loss) per share — diluted attributable to Vicor Corporation |
0.41 | 0.34 | 0.78 | 0.00 | (0.16 | ) | ||||||||||||||
Weighted average shares — basic |
42,186 | 40,330 | 39,872 | 39,228 | 38,842 | |||||||||||||||
Weighted average shares — diluted |
43,869 | 41,677 | 40,729 | 39,933 | 38,842 |
As of December 31, |
||||||||||||||||||||
Balance Sheet Data |
2020 |
2019 |
2018 |
2017 |
2016 |
|||||||||||||||
(In thousands) |
||||||||||||||||||||
Working capital |
$ | 276,419 | $ | 149,136 | $ | 129,062 | $ | 90,796 | $ | 89,545 | ||||||||||
Total assets |
396,239 | 240,727 | 221,068 | 165,724 | 154,067 | |||||||||||||||
Total liabilities |
45,084 | 34,857 | 36,978 | 29,305 | 23,050 | |||||||||||||||
Total equity |
351,155 | 205,870 | 184,090 | 136,419 | 131,017 |
ITEM 7. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
• | Net revenues increased 12.8% to $296,576,000 for 2020, from $262,977,000 for 2019, primarily due to an overall 28.6% increase in bookings for the year ended December 31, 2020, compared to the year ended December 31, 2019, principally due to an increase of 80.9% in new orders for Advanced Products. |
• | Export sales, as a percentage of total revenues, represented approximately 64.4% in 2020 and 53.7% in 2019, principally reflecting the locations of OEMs, ODMs, and contract manufacturers utilizing higher volumes of Advanced Products. |
• | Gross margin increased to $131,447,000 for 2020, from $122,966,000 for 2019. Gross margin, as a percentage of net revenues decreased to 44.3% for 2020 from 46.8% for 2019. Despite higher net revenues and gross margin dollars for the year ended December 31, 2020, gross margin as a percentage of net revenues decreased as compared to the year ended December 31, 2019, primarily due to an unfavorable change in product mix (i.e., a higher percentage of lower margin products were produced and shipped during the year ended December 31, 2020), a negative influence from production inefficiencies and cost variances associated with initial production volumes of new products, certain supply chain constraints associated with the COVID-19 pandemic, and higher tariff charges. |
• | Backlog, representing the total of orders for products received for which shipment is scheduled within the next 12 months, was approximately $147,550,000 at the end of 2020, as compared to $104,164,000 at the end of 2019. |
• | Operating expenses for 2020 increased $4,934,000, or 4.5%, to $114,079,000 from $109,145,000 for 2019, due to increases in research and development expenses of $4,328,000 and selling, general, and administrative expenses of $606,000. Compensation and related personnel costs closely track headcount and annual merit-based increases in salary and wages. However, certain other expenses, such as prototyping costs in research and development, or advertising and promotion costs associated with sales initiatives, can vary meaningfully period to period. |
• | We reported net income for 2020 of $17,910,000, or $0.41 per diluted share, compared to net income of $14,098,000, or $0.34 per diluted share, for 2019. Diluted shares outstanding at year-end 2020 increased approximately 2.2 million over the prior year-end, as a result of the June 2020 underwritten offering of Common Stock and employee exercise of stock options during the year. |
• | In 2020, as a result of activities associated with our construction and capacity expansion, depreciation and amortization totaled $11,056,000, and capital expenditures were $28,653,000, compared to $10,334,000 and $12,485,000, respectively, for 2019. |
• | Inventories increased by approximately $8,082,000, or 16.4%, to $57,269,000 at the end of 2020, as compared to $49,187,000 at the end of 2019, primarily due to an increase in raw materials of $9,972,000 to meet increasing demand, partially offset by an increase in reserves of $3,442,000. |
Year Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Net revenues |
100.0 | % | 100.0 | % | 100.0 | % | ||||||
Gross margin |
44.3 | % | 46.8 | % | 47.7 | % | ||||||
Selling, general and administrative expenses |
21.3 | % | 23.8 | % | 21.4 | % | ||||||
Research and development expenses |
17.2 | % | 17.7 | % | 15.2 | % | ||||||
Income before income taxes |
6.2 | % | 5.7 | % | 11.3 | % |
Increase |
||||||||||||||||
2020 |
2019 |
$ |
% |
|||||||||||||
Brick Products |
$ | 190,256 | $ | 187,896 | $ | 2,360 | 1.3 | % | ||||||||
Advanced Products |
106,320 | 75,081 | 31,239 | 41.6 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
$ | 296,576 | $ | 262,977 | $ | 33,599 | 12.8 | % | ||||||||
|
|
|
|
|
|
Increase (decrease) |
||||||||
Compensation |
$ | 3,153 | 8.2 | %(1) | ||||
Depreciation and amortization |
318 | 11.3 | %(2) | |||||
Legal fees |
231 | 14.5 | %(3) | |||||
Facilities allocations |
(137 | ) | (8.3 | )% | ||||
Outside services |
(191 | ) | (8.7 | )%(4) | ||||
Advertising expenses |
(281 | ) | (8.5 | )%(5) | ||||
Commissions |
(326 | ) | (9.1 | )%(6) | ||||
Travel expense |
(1,973 | ) | (63.3 | )%(7) | ||||
Other, net |
(188 | ) | (3.2 | )% | ||||
|
|
|||||||
$ | 606 | 1.0 | % | |||||
|
|
(1) | Increase primarily attributable to merit-based compensation increases for non-exempt hourly employees in May 2020, increases in headcount and higher stock-based compensation expense associated with stock options awarded in June 2020. |
(2) | Increase attributable to net additions of furniture and fixtures and capitalization of building improvements. |
(3) | Increase primarily attributable to higher use of outside legal services associated with the December 2019 ransomware incident, which carried into the first quarter of 2020, and other corporate legal matters. |
(4) | Decrease primarily attributable to a decrease in the use of outside service providers at our Andover, MA facility. |
(5) | Decrease primarily attributed to decreases in sales support expenses, direct mailings, and advertising in trade publications. |
(6) | Decrease primarily attributable to the decline in net revenues subject to commissions. |
(7) | Decrease primarily attributable to reduced travel by our sales and marketing personnel, due to travel restrictions caused by the COVID-19 pandemic. |
Increase (decrease) |
||||||||
Compensation |
$ | 2,613 | 7.9 | %(1) | ||||
Deferred costs |
1,004 | 57.6 | %(2) | |||||
Project and pre-production materials |
789 | 11.3 | %(3) | |||||
Computer expense |
170 | 33.3 | % | |||||
Depreciation and amortization |
164 | 9.1 | % | |||||
Overhead absorption |
(296 | ) | (33.1 | )%(4) | ||||
Other, net |
(116 | ) | (1.7 | )% | ||||
|
|
|||||||
$4,328 | 9.3% | |||||||
|
|
(1) | Increase primarily attributable to merit-based compensation increases for non-exempt hourly employees in May 2020, increases in headcount, and higher stock-based compensation expense associated with stock options awarded in June 2020. |
(2) | Increase primarily attributable to a decrease in the capitalization of costs for certain non-recurring engineering projects for which the related revenues have been deferred. |
(3) | Increase primarily attributable to higher spending for new product development of Advanced Products. |
(4) | Decrease primarily attributable to a decrease in research and development (“R&D”) personnel incurring time on production activities, compared to R&D activities. |
2020 |
2019 |
Increase (decrease) |
||||||||||
Rental income |
$ | 792 | $ | 792 | $ | — | ||||||
Foreign currency gains (losses), net |
181 | (108 | ) | 289 | ||||||||
Interest income |
95 | 300 | (205 | ) | ||||||||
Gain on disposal of equipment |
13 | 38 | (25 | ) | ||||||||
Credit gains on available-for-sale |
4 | 4 | — | |||||||||
Other |
8 | 40 | (32 | ) | ||||||||
|
|
|
|
|
|
|||||||
$ | 1,093 | $ | 1,066 | $ | 27 | |||||||
|
|
|
|
|
|
2020 |
2019 |
|||||||
Provision for income taxes |
$ | 539 | $ | 778 | ||||
Effective income tax rate |
2.9 | % | 5.2 | % |
Increase (decrease) |
||||
Cash and cash equivalents |
$ | 77,074 | ||
Short-term investments |
50,166 | |||
Accounts receivable |
2,884 | |||
Inventories |
8,082 | |||
Other current assets |
(340 | ) | ||
Accounts payable |
(5,116 | ) | ||
Accrued compensation and benefits |
(3,684 | ) | ||
Accrued expenses |
66 | |||
Sales allowances |
144 | |||
Short-term lease liabilities |
(109 | ) | ||
Income taxes payable |
(82 | ) | ||
Short-term deferred revenue and customer prepayments |
(1,802 | ) | ||
|
|
|||
$ | 127,283 | |||
|
|
Payments Due by Period |
||||||||||||||||||||
Contractual Obligations |
Total |
Less than 1 Year |
Years 2 & 3 |
Years 4 & 5 |
More Than 5 Years |
|||||||||||||||
Operating lease obligations (1) |
$ | 4,919 | $ | 1,740 | $ | 2,199 | $ | 980 | $ | — | ||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | For further information, refer to Note 13 to the Consolidated Financial Statements, Leases 10-K. |
ITEM 8. |
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
Page |
||||
FINANCIAL STATEMENTS |
||||
41 | ||||
43 | ||||
44 | ||||
45 | ||||
46 | ||||
47 | ||||
48 | ||||
80 |
• | assessing historical consumption as a predictor of future product demand by comparing it to trends in industry publications |
• | examining the historical accuracy of the Company’s prior estimates by considering subsequent sales and write off activity |
• | evaluating the adjustments made to forecast future demand based on historical usage data |
• | interviewing operational personnel of the Company involved in purchasing and manufacturing to evaluate product innovations, changes in customer mix, and other factors that may impact expected future sales and usage of raw material inventory. |
2020 |
2019 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Short-term investments |
— | |||||||
Accounts receivable, less allowance of $ |
||||||||
Inventories, net |
||||||||
Other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Long-term deferred tax assets |
||||||||
Long-term investment, net |
||||||||
Property, plant and equipment, net |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
LIABILITIES AND EQUITY |
| |||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued compensation and benefits |
||||||||
Accrued expenses |
||||||||
Sales allowances |
||||||||
Short-term lease liabilities |
||||||||
Income taxes payable |
||||||||
Short-term deferred revenue and customer prepayments |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Long-term deferred revenue |
||||||||
Contingent consideration obligations |
||||||||
Long-term income taxes payable |
||||||||
Long-term lease liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
Commitments and contingencies (Note 17) |
||||||||
Equity: |
||||||||
Vicor Corporation stockholders’ equity: |
||||||||
Class B Common Stock: |
||||||||
Common Stock: |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Treasury stock at cost: |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Vicor Corporation stockholders’ equity |
||||||||
Noncontrolling interest |
||||||||
|
|
|
|
|||||
Total equity |
||||||||
|
|
|
|
|||||
Total liabilities and equity |
$ | $ | ||||||
|
|
|
|
2020 |
2019 |
2018 |
||||||||||
Net revenues |
$ | $ | $ | |||||||||
Cost of revenues |
||||||||||||
|
|
|
|
|
|
|||||||
Gross margin |
||||||||||||
Operating expenses: |
||||||||||||
Selling, general and administrative |
||||||||||||
Research and development |
||||||||||||
Severance and other charges |
— | — | ||||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Income from operations |
||||||||||||
Other income (expense), net: |
||||||||||||
Total unrealized gains (losses) on available-for-sale |
( |
) | ||||||||||
Portion of losses (gains) recognized in other comprehensive income (loss) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net credit gains recognized in earnings |
||||||||||||
Other income (expense), net |
||||||||||||
|
|
|
|
|
|
|||||||
Total other income (expense), net |
||||||||||||
|
|
|
|
|
|
|||||||
Income before income taxes |
||||||||||||
Less: Provision for income taxes |
||||||||||||
|
|
|
|
|
|
|||||||
Consolidated net income |
||||||||||||
Less: Net income attributable to noncontrolling interest |
||||||||||||
|
|
|
|
|
|
|||||||
Net income attributable to Vicor Corporation |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Net income per common share attributable to Vicor Corporation: |
||||||||||||
Basic |
$ | $ | $ | |||||||||
Diluted |
$ | $ | $ | |||||||||
Shares used to compute net income per common share attributable to Vicor Corporation: |
||||||||||||
Basic |
||||||||||||
Diluted |
2020 |
2019 |
2018 |
||||||||||
Consolidated net income |
$ | $ | $ | |||||||||
Foreign currency translation gains, net of tax benefit (1) |
||||||||||||
Unrealized losses on available-for-sale |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Other comprehensive income |
||||||||||||
|
|
|
|
|
|
|||||||
Consolidated comprehensive income |
||||||||||||
Less: Comprehensive income attributable to noncontrolling interest |
||||||||||||
|
|
|
|
|
|
|||||||
Comprehensive income attributable to Vicor Corporation |
$ | $ | $ | |||||||||
|
|
|
|
|
|
(1) | The deferred tax assets associated with cumulative foreign currency translation gains and cumulative unrealized losses on available for sale securities are completely offset by a tax valuation allowance as of December 31, 2020, 2019, and 2018. Therefore, there is |
2020 |
2019 |
2018 |
||||||||||
Operating activities: |
||||||||||||
Consolidated net income |
$ | $ | $ | |||||||||
Adjustments to reconcile consolidated net income to net cash provided by operating activities: |
||||||||||||
Depreciation and amortization |
||||||||||||
Stock-based compensation expense |
||||||||||||
(Decrease) increase in long-term deferred revenue |
( |
) | ( |
) | ||||||||
Increase in long-term income taxes payable |
||||||||||||
Deferred income taxes |
( |
) | ( |
) | ||||||||
Increase in other long-term liabilities |
— | — | ||||||||||
Gain on disposal of equipment |
( |
) | ( |
) | ( |
) | ||||||
Provision (recovery) for doubtful accounts |
( |
) | ||||||||||
Credit gain on available-for-sale |
( |
) | ( |
) | ( |
) | ||||||
Increase in contingent consideration obligations |
— | — | ||||||||||
Change in current assets and liabilities, net |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Net cash provided by operating activities |
||||||||||||
Investing activities: |
||||||||||||
Purchases of short-term investments |
( |
) | — | — | ||||||||
Additions to property, plant and equipment |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from sale of equipment |
||||||||||||
Decrease (increase) in other assets |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash used for investing activities |
( |
) | ( |
) | ( |
) | ||||||
Financing activities: |
||||||||||||
Proceeds from public offering of Common Stock |
— | — | ||||||||||
Proceeds from employee stock plans |
||||||||||||
Payment of contingent consideration obligations |
( |
) | ( |
) | ( |
) | ||||||
Noncontrolling interest dividend paid |
— | ( |
) | — | ||||||||
|
|
|
|
|
|
|||||||
Net cash provided by financing activities |
||||||||||||
Effect of foreign exchange rates on cash |
||||||||||||
|
|
|
|
|
|
|||||||
Net increase in cash and cash equivalents |
||||||||||||
Cash and cash equivalents at beginning of year |
||||||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents at end of year |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Change in current assets and liabilities: |
||||||||||||
Accounts receivable |
$ | ( |
) | $ | $ | ( |
) | |||||
Inventories, net |
( |
) | ( |
) | ( |
) | ||||||
Other current assets |
( |
) | ||||||||||
Accounts payable and accrued liabilities |
( |
) | ||||||||||
Accrued severance and other charges |
— | ( |
) | |||||||||
Short-term lease payable |
— | |||||||||||
Income taxes payable |
( |
) | ||||||||||
Deferred revenue |
||||||||||||
|
|
|
|
|
|
|||||||
Change in current assets and liabilities, net |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Supplemental disclosures: |
||||||||||||
Cash paid during the year for income taxes, net of refunds |
$ | $ | $ |
Class B Common Stock |
Common Stock |
Additional Paid-In Capital |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Treasury Stock |
Total Vicor Corporation Stockholders’ Equity |
Noncontrolling Interest |
Total Equity |
||||||||||||||||||||||||||||
Balance on December 31, 2017 |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | |||||||||||||||||||||||
Issuance of Common Stock under employee stock plans |
||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||||||||||
Cumulative effect of adoption of new accounting principle (Topic 606) |
||||||||||||||||||||||||||||||||||||
Other |
( |
) | ||||||||||||||||||||||||||||||||||
Components of comprehensive income, net of ta x |
||||||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||||||
Other comprehensive income |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total comprehensive income |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance on December 31, 2018 |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Issuance of Common Stock under employee stock plans |
||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||||||||||
Noncontrolling interest dividend paid |
— | ( |
) | ( |
) | |||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||
Components of comprehensive income, net of tax |
||||||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||||||
Other comprehensive income |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total comprehensive income |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance on December 31, 2019 |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Issuance of Common Stock under employee stock plans |
||||||||||||||||||||||||||||||||||||
Issuance of Common Stock in public offering, net (See Note 1 0 ) |
||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
||||||||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||||||
Components of comprehensive income, net of tax |
||||||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||||||
Other comprehensive income |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total comprehensive income |
||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance on December 31, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 1 |
Inputs used to measure fair value are unadjusted quoted prices available in active markets for the identical assets or liabilities as of the reporting date. | |
Level 2 |
Inputs used to measure fair value, other than quoted prices included in Level 1, are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in inactive markets. Level 2 also includes assets and liabilities valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data from actively quoted markets for substantially the full term of the financial instrument. | |
Level 3 |
Inputs used to measure fair value are unobservable inputs supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions. |
2020 |
2019 |
2018 |
||||||||||
Numerator: |
||||||||||||
Net income attributable to Vicor Corporation |
$ | $ | $ | |||||||||
Denominator: |
||||||||||||
Denominator for basic net income per share-weighted average shares (1) |
||||||||||||
Effect of dilutive securities: |
||||||||||||
Employee stock options (2) |
||||||||||||
Denominator for diluted net income per share-adjusted weighted-average shares and assumed conversions (3) |
||||||||||||
Basic net income per share |
$ | $ | $ | |||||||||
Diluted net income per share |
$ | $ | $ | |||||||||
(1) | Denominator represents weighted average number of Common Shares and Class B Common Shares outstanding. |
(2) | Options to purchase |
(3) | Denominator represents weighted average number of Common Shares and Class B Common Shares outstanding for the year, adjusted to include the dilutive effect, if any, of outstanding options. |
2020 |
2019 |
|||||||
Raw materials |
$ | $ | ||||||
Work-in-process |
||||||||
Finished goods |
||||||||
$ | $ | |||||||
December 31, 2020 |
||||||||||||
Cash and Cash Equivalents |
Short-Term Investments |
Long-Term Investments |
||||||||||
Measured at fair value: |
||||||||||||
Available-for-sale |
||||||||||||
Money Market Funds |
$ | $ | — | $ | — | |||||||
U.S. Treasury Obligations |
— | |||||||||||
Failed Auction Security |
— | — | ||||||||||
Total |
||||||||||||
Other measurement basis: |
||||||||||||
Cash on hand |
— | — | ||||||||||
Total |
$ | $ | $ | |||||||||
December 31, 2019 |
||||||||||||
Cash and Cash Equivalents |
Short-Term Investments |
Long-Term Investments |
||||||||||
Measured at fair value: |
||||||||||||
Available-for-sale |
||||||||||||
Money Market Funds |
$ | $ | — | $ | — | |||||||
Failed Auction Security |
— | — | ||||||||||
Total |
— | |||||||||||
Other measurement basis: |
||||||||||||
Cash on hand |
— | — | ||||||||||
Total |
$ | $ | — | $ | ||||||||
December 31, 2020 |
Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Estimated Fair Value |
||||||||||||
U.S. Treasury Obligations |
$ | $ | — | $ | $ | |||||||||||
Failed Auction Security |
— | |||||||||||||||
December 31, 2019 |
||||||||||||||||
Failed Auction Security |
$ | $ | — | $ | $ | |||||||||||
U.S. Treasury Obligations: |
||||||||
Cost |
Estimated Fair Value |
|||||||
Maturities greater than three months but less than one year |
$ |
$ |
||||||
Maturities less than three months | ||||||||
$ |
$ |
|||||||
Failed Auction Security: |
||||||||
Cost |
Estimated Fair Value |
|||||||
Due in twenty to forty years |
$ | $ | ||||||
2020 |
2019 |
2018 |
||||||||||
Balance at the beginning of the period |
$ | $ | $ | |||||||||
Reductions in the amount related to credit gain for which other-than-temporary impairment was not previously recognized |
( |
) | ( |
) | ( |
) | ||||||
Balance at the end of the period |
$ | $ | $ | |||||||||
Using |
||||||||||||||||
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
Total Fair Value as of December 31, 2020 |
|||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | $ | — | $ | — | $ | ||||||||||
U.S. Treasury Obligations |
— | — | ||||||||||||||
Short-term investments: |
||||||||||||||||
U.S. Treasury Obligations |
— | — | ||||||||||||||
Long-term investments: |
||||||||||||||||
Failed Auction Security |
— | — | ||||||||||||||
Liabilities: |
||||||||||||||||
Contingent consideration obligations |
— | — | ( |
) | ( |
) |
Using |
||||||||||||||||
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Unobservable Inputs (Level 3) |
Total Fair Value as of December 31, 2019 |
|||||||||||||
Cash equivalents: |
||||||||||||||||
Money market funds |
$ | $ | — | $ | — | $ | ||||||||||
Long-term investments: |
||||||||||||||||
Failed Auction Security |
— | — | ||||||||||||||
Liabilities: |
||||||||||||||||
Contingent consideration obligations |
— | — | ( |
) | ( |
) |
Fair Value |
Valuation Technique |
Unobservable Input |
Weighted Average |
|||||||||
Failed Auction Security |
$ |
% | ||||||||||
% | ||||||||||||
% | ||||||||||||
% | ||||||||||||
% |
Balance at the beginning of the period |
$ | |||
Credit gain on available-for-sale |
||||
Gain included in Other comprehensive income |
||||
|
|
|||
Balance at the end of the period |
$ | |||
|
|
Balance at the beginning of the period |
$ | |||
Payments |
( |
) | ||
|
|
|||
Balance at the end of the period |
$ | |||
|
|
2020 |
2019 |
|||||||
Land |
$ | $ | ||||||
Buildings and improvements |
||||||||
Machinery and equipment |
||||||||
Furniture and fixtures |
||||||||
Construction in-progress and deposits |
||||||||
|
|
|
|
|||||
Accumulated depreciation and amortization |
( |
) | ( |
) | ||||
Right of use asset — net |
||||||||
|
|
|
|
|||||
Net balance |
$ | $ | ||||||
|
|
|
|
2020 |
2019 |
|||||||
Patent costs |
$ | $ | ||||||
Accumulated amortization |
( |
) | ( |
) | ||||
|
|
|
|
|||||
$ | $ | |||||||
|
|
|
|
2020 |
2019 |
2018 |
||||||||||
Balance at the beginning of the period |
$ | $ | $ | |||||||||
Accruals for warranties for products sold in the period |
||||||||||||
Fulfillment of warranty obligations |
( |
) | ( |
) | ( |
) | ||||||
Revisions of estimated obligations |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Balance at the end of the period |
$ | $ | $ | |||||||||
|
|
|
|
|
|
Twelve Months Ended December 31, 2020 |
||||||||||||
Brick Products |
Advanced Products |
Total |
||||||||||
United States |
$ | $ | $ | |||||||||
Europe |
||||||||||||
Asia Pacific |
||||||||||||
All other |
||||||||||||
$ | $ | $ | ||||||||||
Twelve Months Ended December 31, 2019 |
||||||||||||
Brick Products |
Advanced Products |
Total |
||||||||||
United States |
$ | $ | $ | |||||||||
Europe |
||||||||||||
Asia Pacific |
||||||||||||
All other |
||||||||||||
$ | $ | $ | ||||||||||
Twelve Months Ended December 31, 2018 |
||||||||||||
Brick Products |
Advanced Products |
Total |
||||||||||
United States |
$ |
$ |
$ |
|||||||||
Europe |
||||||||||||
Asia Pacific |
||||||||||||
All other |
||||||||||||
$ |
$ |
$ |
||||||||||
Twelve Months Ended December 31, 2020 |
||||||||||||
Brick Products |
Advanced Products |
Total |
||||||||||
Direct customers, contract manufacturers and non-stocking distributors |
$ | $ | $ | |||||||||
Stocking distributors, net of sales allowances |
||||||||||||
Non-recurring engineering |
||||||||||||
Royalties |
— | |||||||||||
Other |
— | |||||||||||
$ | $ | $ | ||||||||||
Twelve Months Ended December 31, 2019 |
||||||||||||
Brick Products |
Advanced Products |
Total |
||||||||||
Direct customers, contract manufacturers and non-stocking distributors |
$ | $ | $ | |||||||||
Stocking distributors, net of sales allowances |
||||||||||||
Non-recurring engineering |
||||||||||||
Royalties |
||||||||||||
Other |
— | |||||||||||
$ | $ | $ | ||||||||||
Twelve Months Ended December 31, 2018 |
||||||||||||
Brick Products |
Advanced Products |
Total |
||||||||||
Direct customers, contract manufacturers and non-stocking distributors |
$ |
$ |
$ |
|||||||||
Stocking distributors, net of sales allowances |
||||||||||||
Non-recurring engineering |
||||||||||||
Royalties |
||||||||||||
Other |
— |
|||||||||||
$ |
$ |
$ |
||||||||||
December 31, 2020 |
December 31, 2019 |
Change |
||||||||||
Accounts receivable |
$ | $ | $ | |||||||||
Short-term deferred revenue and customer prepayments |
( |
) | ( |
) | ( |
) | ||||||
Long-term deferred revenue |
( |
) | ( |
) | ||||||||
Deferred expenses |
( |
) | ||||||||||
Sales allowances |
( |
) | ( |
) |
2020 |
2019 |
2018 |
||||||||||
United States |
$ | $ | $ | |||||||||
Europe |
||||||||||||
Asia Pacific |
||||||||||||
All other |
||||||||||||
$ | $ | $ | ||||||||||
2020 |
2019 |
2018 |
||||||||||
Cost of revenues |
$ | $ | $ | |||||||||
Selling, general and administrative |
||||||||||||
Research and development |
||||||||||||
Total stock-based compensation |
$ | $ | $ | |||||||||
2020 |
2019 |
2018 |
||||||||||
Stock options |
$ | $ | $ | |||||||||
ESPP |
||||||||||||
Total stock-based compensation |
$ | $ | $ | |||||||||
2020 |
2019 |
2018 |
||||||||||
Risk-free interest rate |
% | % | % | |||||||||
Expected dividend yield |
— | — | — | |||||||||
Expected volatility |
% | % | % | |||||||||
Expected lives (years) |
Options Outstanding |
Weighted- Average Exercise Price |
Weighted- Average Remaining Contractual Life in Years |
Aggregate Intrinsic Value |
|||||||||||||
Outstanding on December 31, 2019 |
$ | |||||||||||||||
Granted |
$ | |||||||||||||||
Forfeited and expired |
( |
) | $ | |||||||||||||
Exercised |
( |
) | $ | |||||||||||||
Outstanding on December 31, 2020 |
$ | $ | ||||||||||||||
Exercisable on December 31, 2020 |
$ | $ | ||||||||||||||
Vested or expected to vest as of December 31, 2020(1) |
$ | $ | ||||||||||||||
(1) | In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options. |
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Total lease payments |
$ | |||
Less: Imputed interest |
||||
Present value of lease liabilities |
$ | |||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
Total lease payments to be received |
$ | |||
2020 |
2019 |
2018 |
||||||||||
Rental income, net |
$ | $ | $ | |||||||||
Foreign currency gains (losses), net |
( |
) | ( |
) | ||||||||
Interest income |
||||||||||||
Gain on disposal of equipment |
||||||||||||
Credit gains on available-for-sale |
||||||||||||
Other |
||||||||||||
$ | $ | $ | ||||||||||
2020 |
2019 |
2018 |
||||||||||
Statutory federal tax rate |
% | % | % | |||||||||
State income taxes, net of federal income tax benefit |
( |
) | ( |
) | ||||||||
Increase (decrease) in valuation allowance |
( |
) | ||||||||||
Permanent items |
( |
) | ( |
) | ( |
) | ||||||
Tax credits |
( |
) | ( |
) | ( |
) | ||||||
Provision vs. tax return differences |
( |
) | ||||||||||
Foreign rate differential and deferred items |
||||||||||||
Change in tax reserves |
— | — | ||||||||||
Other |
— | |||||||||||
2020 |
2019 |
2018 |
||||||||||
Domestic |
$ | $ | $ | |||||||||
Foreign |
||||||||||||
$ | $ | $ | ||||||||||
2020 |
2019 |
2018 |
||||||||||
Current: |
||||||||||||
Federal |
$ | $ | — | $ | — | |||||||
State |
||||||||||||
Foreign |
||||||||||||
Deferred: |
||||||||||||
Foreign |
( |
) | ( |
) | ||||||||
( |
) | ( |
) | |||||||||
$ | $ | $ | ||||||||||
2020 |
2019 |
|||||||
Deferred tax assets: |
||||||||
Research and development tax credit carryforwards |
$ | $ | ||||||
Net operating loss carryforwards |
||||||||
Inventory reserves |
||||||||
Investment tax credit carryforwards |
||||||||
Stock-based compensation |
||||||||
Vacation accrual |
||||||||
UNICAP |
||||||||
Accrued payroll tax deferral |
— | |||||||
Lease liabilities |
||||||||
Other |
||||||||
Total deferred tax assets |
||||||||
Less: Valuation allowance for deferred tax assets |
( |
) | ( |
) | ||||
Net deferred tax assets |
||||||||
Deferred tax liabilities: |
||||||||
Depreciation |
( |
) | ( |
) | ||||
Prepaid expenses |
( |
) | ( |
) | ||||
ROU assets |
( |
) | ( |
) | ||||
Other |
( |
) | ( |
) | ||||
Total deferred tax liabilities |
( |
) | ( |
) | ||||
Net deferred tax assets (liabilities) |
$ | $ | ||||||
2020 |
2019 |
2018 |
||||||||||
Balance on January 1 |
$ | $ | $ | |||||||||
Additions based on tax positions related to the current year |
||||||||||||
(Reductions) additions for tax positions of prior years |
( |
) | ||||||||||
Lapse of statute |
( |
) | ( |
) | ( |
) | ||||||
Balance on December 31 |
$ | $ | $ | |||||||||
First |
Second |
Third |
Fourth |
Total |
||||||||||||||||
2020: |
||||||||||||||||||||
Net revenues |
$ | $ | $ | $ | $ | |||||||||||||||
Gross margin |
||||||||||||||||||||
Consolidated net (loss) income |
( |
) | ||||||||||||||||||
Net income attributable to noncontrolling interest |
||||||||||||||||||||
Net (loss) income attributable to Vicor Corporation |
( |
) | ||||||||||||||||||
Net (loss) income per share attributable to Vicor Corporation: |
||||||||||||||||||||
Basic |
( |
) | ||||||||||||||||||
Diluted |
( |
) | ||||||||||||||||||
First |
Second |
Third |
Fourth |
Total |
||||||||||||||||
2019: |
||||||||||||||||||||
Net revenues |
$ | $ | $ | $ | $ | |||||||||||||||
Gross margin |
||||||||||||||||||||
Consolidated net income |
||||||||||||||||||||
Net income (loss) attributable to noncontrolling interest |
( |
) | ( |
) | ||||||||||||||||
Net income attributable to Vicor Corporation |
||||||||||||||||||||
Net income per share attributable to Vicor Corporation: |
||||||||||||||||||||
Basic |
||||||||||||||||||||
Diluted |
ITEM 9. |
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE |
ITEM 9A. |
CONTROLS AND PROCEDURES |
ITEM 9B. |
OTHER INFORMATION |
ITEM 10. |
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE |
ITEM 11. |
EXECUTIVE COMPENSATION |
ITEM 12. |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS |
ITEM 13. |
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE |
ITEM 14. |
PRINCIPAL ACCOUNTANT FEES AND SERVICES |
* | Indicates a management contract or compensatory plan or arrangement required to be filled pursuant to Item 15(b) of Form 10-K. |
** | Filed with this Annual Report on Form 10-K for the year ended December 31, 2020 are the following documents formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Consolidated |
Balance Sheets for the years ended December 31, 2020 and 2019; (ii) the Consolidated Statements of Operations for the years ended December 31, 2020, 2019 and 2018; (iii) the Consolidated Statements of Comprehensive Income for the years ended December 31, 2020, 2019 and 2018; (iv) the Consolidated Statements of Cash Flows for the years ended December 31, 2020, 2019 and 2018; (v) the Consolidated Statements of Equity for the years ended December 31, 2020, 2019 and 2018; and (vi) the Notes to Consolidated Financial Statements. |
(1) | Filed as an exhibit to the Company’s Annual Report on Form 10-K filed on March 29, 2001 and incorporated herein by reference. |
(2) | Filed as an exhibit to the Company’s Registration Statement on Form 10, as amended, under the Securities Exchange Act of 1934 (File No. 0-18277), and incorporated herein by reference. (P) |
(3) | Filed as an exhibit to the Company’s Registration Statement on Form S-8, as amended, under the Securities Act of 1933 (No. 333-61177), and incorporated herein by reference. |
(4) | Filed as Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed with the SEC on May 1, 2017 (File No. 000-18277), and incorporated herein by reference. |
(5) | Filed as an exhibit to the Company’s Quarterly Report on Form 10-Q filed on November 4, 2004 (File No. 0-18277) and incorporated herein by reference. |
(6) | Filed as an exhibit to the Company’s Annual Report on Form 10-K filed on March 16, 2005 (File No. 0-18277) and incorporated herein by reference. |
(7) | Filed as an exhibit to the Company’s Annual Report on Form 10-K filed on March 14, 2006 (File No. 0-18277) and incorporated herein by reference. |
(8) | Filed as an exhibit to the Company’s Current Report on Form 8-K filed on June 4, 2020 (File No. 0-18277) and incorporated herein by reference. |
(9) | Filed as an exhibit to the Company’s Current Report on Form 8-K, dated June 6, 2007 (File No. 0-18277) and incorporated herein by reference. |
(10) | Filed as an exhibit to the Company’s Current Report and Form 8-K, dated March 6, 2008 (File No. 0-18277) incorporated herein by reference. |
(11) | Filed as Appendix B to the Company’s Definitive Proxy Statement on Schedule 14A filed with the SEC on May 1, 2017 (File No. 000-18277), and incorporated herein by reference. |
(12) | Filed as Appendix C to the Company’s Definitive Proxy Statement on Schedule 14A filed with the SEC on May 1, 2017 (File No. 000-18277), and incorporated herein by reference. |
(13) | Filed as Appendix D to the Company’s Definitive Proxy Statement on Schedule 14A filed with the SEC on May 1, 2017 (File No. 000-18277), and incorporated herein by reference. |
(14) | Filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 5, 2018 (File No. 000-18277), and incorporated herein by reference. |
(15) | Filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-8, under the Securities Act of 1933 (No. 333-232864), and incorporated herein by reference. |
(16) | Filed herewith. |
Description |
Balance at Beginning of Period |
Charge (Recovery)to Costs and Expenses |
Other Charges, Deductions (1) |
Balance at End of Period |
||||||||||||
Allowance for doubtful accounts: |
||||||||||||||||
Year ended: |
||||||||||||||||
December 31, 2020 |
$ | $ | $ | — | $ | |||||||||||
December 31, 2019 |
( |
) | ( |
) | ||||||||||||
December 31, 2018 |
— |
(1) | Reflects uncollectible accounts written off, net of recoveries. |
Vicor Corporation | ||
By: |
/s/ James A. Simms | |
James A. Simms | ||
Vice President, Chief Financial Officer |
Signature |
Title |
Date | ||
/s/ Patrizio Vinciarelli Patrizio Vinciarelli |
President, Chief Executive Officer and Chairman of the Board (Principal Executive Officer) |
March 1, 2021 | ||
/s/ James A. Simms James A. Simms |
Chief Financial Officer and Vice President (Principal Financial Officer and Principal Accounting Officer) |
March 1, 2021 | ||
/s/ Estia J. Eichten Estia J. Eichten |
Director | March 1, 2021 | ||
/s/ Michael S. McNamara Michael S. McNamara |
Director | March 1, 2021 | ||
/s/ Samuel J. Anderson Samuel J. Anderson |
Director | March 1, 2021 | ||
/s/ Claudio Tuozzolo Claudio Tuozzolo |
Director | March 1, 2021 | ||
/s/ Jason L. Carlson Jason L. Carlson |
Director | March 1, 2021 | ||
/s/ Philip D. Davies Philip D. Davies |
Director | March 1, 2021 | ||
/s/ Andrew T. D’Amico Andrew T. D’Amico |
Director | March 1, 2021 |